NCT06448000

Brief Summary

Sperm cryopreservation is an essential tool for men fertility preservation in the context of gonadotoxic treatments or/and pathologies such as cancers, gamete donation and ART. Nevertheless, it is validated that the freezing and thawing procedures affect sperm parameters and in particular motility. It is therefore essential to determine the impact of storage time on motility and particularly the number of progressive motile spermatozoa which will determine the choice of ART technique. However, few studies have analyzed the impact of storage time in liquid nitrogen and no study over a long period on human spermatozoa and their use in ART. The aim of this study is to assess the impact of long-time storage, from 2 to 12 years, in liquid nitrogen on standard semen parameters, notably motility.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
10.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2020

Completed
2.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

June 3, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 7, 2024

Completed
Last Updated

June 7, 2024

Status Verified

March 1, 2024

Enrollment Period

10.8 years

First QC Date

June 3, 2024

Last Update Submit

June 3, 2024

Conditions

Keywords

Cryopreservationsemen standard parametersliquid nitrogenhigh security strawslong term storageprogressive and total mobility

Outcome Measures

Primary Outcomes (1)

  • To evaluate and compare the total and progressive mobility of human spermatozoa post-freezing and post-storage in High Security straws.

    The percentage of total and progressive motile human spermatozoa were assessed according to WHO, 2010 guideline.

    07/2022 to 03/2023

Secondary Outcomes (2)

  • To compare the vitality of post-freezing and post-storage human spermatozoa

    07/2022 to 03/2023

  • To compare the number of motile, total and progressive spermatozoa post-freezing and post-storage

    07/2022 to 03/2023

Study Arms (2)

Group 1

Same semen samples are analyzed in group 1 and 2. Group 1 correspond to ejaculate semen samples analyzed the day of slow-freezing

Group 2

Same semen samples are analyzed in group 1 and 2. Group 2 correspond to the same ejaculate semen samples as group 1 but analyzed after a storage time from 2 to 12 years in liquid nitrogen.

Eligibility Criteria

Age19 Years - 63 Years
Sexmale
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All samples frozen between 2010 and 2020 corresponding to the inclusion criteria cited above have been included in the study. In total, this corresponds to 101 eligible samples, or 202 straws, between 2010 and 2020, i.e. a T1 storage time studied from 2 to 12 years.

You may qualify if:

  • The ejaculates were frozen in high security straws by slow freezing,
  • At least two straws per sample were available
  • The "post-freezing" thawing test was carried out on the day of freezing
  • The "post-freezing" thawing test carried out at T0 includes cell numbering, vitality and mobility
  • There is the informed signature of the consent to donate the straws to Research by the patient

You may not qualify if:

  • Ejaculate not donated to research, lack of consent to donation to research
  • Frozen ejaculate in microdrop
  • Thawing test not carried out or incomplete

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital

Clermont-Ferrand, 63100, France

Location

MeSH Terms

Conditions

NeoplasmsInfertility, Male

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesInfertilityMale Urogenital Diseases

Study Officials

  • Hanae Pons-Rejraji, PhD

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR
  • Florence Brugnon, MD, PhD

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 3, 2024

First Posted

June 7, 2024

Study Start

January 1, 2010

Primary Completion

October 1, 2020

Study Completion

March 1, 2023

Last Updated

June 7, 2024

Record last verified: 2024-03

Locations